台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    42.30
  • 漲跌
    ▼0.40
  • 漲幅
    -0.94%
  • 成交量
    132
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
生華科 (6492)籌碼相關-元大-竹科 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-竹科 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/2600.000.144.3044.05-0.1429-0.01%
2024/12/09044.1500.0043.8006000.00%
2024/12/0600.00444.2044.15-4611-0.65%
2024/12/02045.4500.0045.4006340.01%
2024/11/2700.00044.8544.2006550.00%
2024/11/21044.6500.0045.6506710.00%
2024/10/28653.9712555.6552.60-119756-15.73% 大賣/鉅額交易
2024/10/2513053.211052.5054.4012064518.58% 大買/鉅額交易
2024/10/2100.00150.4049.90-1660-0.15%
2024/10/07052.0000.0052.1001,0520.00%
2024/10/0400.002052.6652.40-201,052-1.90%
2024/09/30555.8000.0054.4051,0460.48%
2024/09/2600.00552.3851.90-51,023-0.49%
2024/09/25454.1000.0053.8041,0180.39%
2024/09/24454.6000.0053.4041,0190.39%
2024/09/231555.8000.0054.60151,0191.47%
2024/09/20154.80154.7055.0001,0230.00%
2024/09/19154.90554.5853.20-4995-0.40%
2024/09/16448.00047.8047.6049430.42%
2024/09/04049.5000.0047.8501,0170.00%
2024/09/02150.5000.0050.7011,0030.10%
2024/08/3000.00450.9051.30-4999-0.40%
2024/08/1900.00150.0049.80-1930-0.11%
2024/08/16150.20149.2550.1009280.00%
2024/08/15449.8500.0049.6049170.44%
2024/08/1300.00147.5047.10-1894-0.11%
2024/08/07150.40150.4050.7008560.00%
2024/08/06247.7000.0049.0028410.24%
2024/08/0500.00250.0047.70-2818-0.24%
2024/08/02554.88554.6453.0008090.00%
2024/08/01155.7000.0055.4018040.12%
2024/07/29456.58756.8656.90-3788-0.38%
2024/07/26454.5800.0054.5047760.51%
2024/07/19661.03358.9058.1037350.41%
2024/07/18560.54662.6862.20-1658-0.15%
2024/07/17458.681258.5158.90-8543-1.47%
2024/07/16657.027856.9957.20-72427-16.83%
2024/07/1500.00152.0052.00-1337-0.30%
2024/07/127747.3000.0047.307732823.41%
2024/07/11143.2000.0043.0013180.31%
2024/07/0900.00143.0543.40-1319-0.31%
2024/07/0200.001746.4445.50-17307-5.53%
2024/07/0100.00147.1547.10-1302-0.33%
2024/06/281648.2000.0047.10162995.34%
2024/06/26548.70848.7248.75-3288-1.04%
2024/06/2500.001444.6545.20-14264-5.29%
2024/06/201348.78148.0547.60122504.78%
2024/06/1900.00147.6547.95-1224-0.44%
2024/06/18745.9700.0044.0072133.27%
2024/06/17244.9500.0045.3521871.07%
2024/06/1300.00141.6041.45-1153-0.65%
2024/06/04242.1000.0041.8021531.30%
2024/06/03041.65042.0041.6501580.00%
2024/05/3100.00441.9041.70-4160-2.49%
2024/05/3000.00841.7441.35-8160-4.98%
2024/05/2800.00242.0542.30-2164-1.21%
2024/04/25240.8000.0040.7021821.10%
2024/04/11044.5000.0043.5501890.00%
2024/03/28044.7300.0043.4001990.00%
2024/03/1400.00243.1542.90-2205-0.97%
2024/03/0100.00144.9044.25-1344-0.29%
2024/02/2300.001045.0544.95-10394-2.54%
2024/02/15246.2000.0046.0024360.46%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音